LISDEXAMFETAMINE 10 MG CAPSULE

lisdexamfetamine dimesylate
$2.8820per EA
DEA Schedule CII

Strength

10 mg/1

Manufacturer

Alvogen Inc.

NDC

47781056201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA214547

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-6.3%

3M

-18.7%

6M

-9.4%

1Y

-31.5%

3Y

N/A

5Y

N/A

All

-51.0%